Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells
Authors
Keywords
B cells, Toll-like receptors, Sequence motif analysis, Secretion, Systemic lupus erythematosus, Immune cells, Interferons, Dendritic cells
Journal
PLoS One
Volume 10, Issue 2, Pages e0116703
Publisher
Public Library of Science (PLoS)
Online
2015-02-20
DOI
10.1371/journal.pone.0116703
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lupus Nephritis: The Evolving Role of Novel Therapeutics
- (2014) Brad H. Rovin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
- (2014) A. Forsbach et al. JOURNAL OF IMMUNOLOGY
- TLRs and interferons: a central paradigm in autoimmunity
- (2013) Dwight H. Kono et al. CURRENT OPINION IN IMMUNOLOGY
- Guanine Modification of Inhibitory Oligonucleotides Potentiates Their Suppressive Function
- (2013) F. Rommler et al. JOURNAL OF IMMUNOLOGY
- Role of Nucleic Acid-Sensing TLRs in Diverse Autoantibody Specificities and Anti-Nuclear Antibody-Producing B Cells
- (2013) Y. T. Koh et al. JOURNAL OF IMMUNOLOGY
- Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
- (2011) Ana M. Avalos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Love Triangle between Unc93B1, TLR7, and TLR9 Prevents Fatal Attraction
- (2011) Miwa Sasai et al. IMMUNITY
- Unc93B1 Restricts Systemic Lethal Inflammation by Orchestrating Toll-like Receptor 7 and 9 Trafficking
- (2011) Ryutaro Fukui et al. IMMUNITY
- Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity
- (2011) Takumi Kawasaki et al. IMMUNOLOGICAL REVIEWS
- Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding
- (2011) Robert F. Ashman et al. INTERNATIONAL IMMUNOLOGY
- Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9
- (2011) Robert F. Ashman et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Classification, Mechanisms of Action, and Therapeutic Applications of Inhibitory Oligonucleotides for Toll-Like Receptors (TLR) 7 and 9
- (2010) Petar S. Lenert MEDIATORS OF INFLAMMATION
- TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
- (2010) Cristiana Guiducci et al. NATURE
- Identification of new SLE-associated genes with a two-step Bayesian study design
- (2009) D L Armstrong et al. GENES AND IMMUNITY
- HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses
- (2009) Hideyuki Yanai et al. NATURE
- DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo
- (2009) Petar Lenert et al. ARTHRITIS RESEARCH & THERAPY
- UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
- (2008) You-Me Kim et al. NATURE
- The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
- (2008) Sarah E. Ewald et al. NATURE
- Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9
- (2008) Boyoun Park et al. NATURE IMMUNOLOGY
- Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity
- (2007) Mirjam Peter et al. IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started